M Trademark

Trademark Overview


On Friday, December 1, 2017, a trademark application was filed for M with the United States Patent and Trademark Office. The USPTO has given the M trademark a serial number of 79225539. The federal status of this trademark filing is REGISTERED as of Tuesday, January 29, 2019. This trademark is owned by MAAT PHARMA. The M trademark is filed in the Pharmaceutical Products, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:

[ Education, namely classes, seminars, workshops, in the field of, microbiotherapy, bacteriology, gut microbiota and microbiome-based drugs; training in the field of microbiotherapy, bacteriology, gut microbiota and microbiome-based drugs; training, namely, organization and conducting of colloquiums, conferences, congresses, seminars in the field of microbiotherapy, bacteriology, gut microbiota and microbiome-based drugs; education, namely, arranging of exhibitions for educational purposes; training, namely, arranging and conducting workshops in the field of microbiotherapy, bacteriology, gut microbiota and microbiome-based drugs; training in the field of microbiotherapy ]

[ Evaluations and assessments in the fields of science and technology provided by engineers; scientific and technical research in the field of biomarkers, nutrition, microbiotherapy, bacteriotherapy, and therapies meant to have an effect on the gut microbiota functions; research and development of new products for others; technical project studies namely, engineering services in the nature of technical project planning for the manufacture, control and traceability of pharmaceutical products having an effect on gut microbiota or biomarkers aiming at characterizing the gut microbiota; chemical analysis; chemistry services namely, laboratory research in the field of chemistry; conducting clinical trials for others; surveying engineering work; scientific laboratory services; research in biology, bacteriology, chemistry and physics; scientific research in the field of microbiotherapy ]

Pharmaceutical and veterinary products, namely, preparations for the treatment of gut dysbiosis related diseases; food supplements for humans and animals; dietary supplements for humans and animals, namely, nutritional supplements; dietary supplements for humans and animals, namely, dietetic food and beverages for medical or veterinary use; chemical preparations for medical or pharmaceutical use, namely, for the treatment of gut dysbiosis related diseases; chemical preparations for pharmaceutical or medical use, namely, microbiotherapy preparations for the repair of intestinal microbiome; bacteriological preparations for medical or veterinary use; bacterial preparations for medical or veterinary use; biological preparations for medical or veterinary use, namely for the treatment of gut dysbiosis related diseases; culture media for bacteriology; chemico-pharmaceutical preparations, namely, for the treatment of gut dysbiosis related diseases; microbiotherapy preparations for medical use ...
m

General Information


Serial Number79225539
Word MarkM
Filing DateFriday, December 1, 2017
Status700 - REGISTERED
Status DateTuesday, January 29, 2019
Registration Number5663397
Registration DateTuesday, January 29, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 13, 2018

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of a letter "M" with a stylized depiction of a feather appearing to the left.
Goods and Services[ Education, namely classes, seminars, workshops, in the field of, microbiotherapy, bacteriology, gut microbiota and microbiome-based drugs; training in the field of microbiotherapy, bacteriology, gut microbiota and microbiome-based drugs; training, namely, organization and conducting of colloquiums, conferences, congresses, seminars in the field of microbiotherapy, bacteriology, gut microbiota and microbiome-based drugs; education, namely, arranging of exhibitions for educational purposes; training, namely, arranging and conducting workshops in the field of microbiotherapy, bacteriology, gut microbiota and microbiome-based drugs; training in the field of microbiotherapy ]
Goods and Services[ Evaluations and assessments in the fields of science and technology provided by engineers; scientific and technical research in the field of biomarkers, nutrition, microbiotherapy, bacteriotherapy, and therapies meant to have an effect on the gut microbiota functions; research and development of new products for others; technical project studies namely, engineering services in the nature of technical project planning for the manufacture, control and traceability of pharmaceutical products having an effect on gut microbiota or biomarkers aiming at characterizing the gut microbiota; chemical analysis; chemistry services namely, laboratory research in the field of chemistry; conducting clinical trials for others; surveying engineering work; scientific laboratory services; research in biology, bacteriology, chemistry and physics; scientific research in the field of microbiotherapy ]
Goods and ServicesPharmaceutical and veterinary products, namely, preparations for the treatment of gut dysbiosis related diseases; food supplements for humans and animals; dietary supplements for humans and animals, namely, nutritional supplements; dietary supplements for humans and animals, namely, dietetic food and beverages for medical or veterinary use; chemical preparations for medical or pharmaceutical use, namely, for the treatment of gut dysbiosis related diseases; chemical preparations for pharmaceutical or medical use, namely, microbiotherapy preparations for the repair of intestinal microbiome; bacteriological preparations for medical or veterinary use; bacterial preparations for medical or veterinary use; biological preparations for medical or veterinary use, namely for the treatment of gut dysbiosis related diseases; culture media for bacteriology; chemico-pharmaceutical preparations, namely, for the treatment of gut dysbiosis related diseases; microbiotherapy preparations for medical use for the repair of intestinal microbiome

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 29, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateMonday, January 29, 2018
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 29, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMAAT PHARMA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLyon F-69007
FR

Party NameMAAT PHARMA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR

Party NameMAAT PHARMA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events


Event DateEvent Description
Thursday, January 25, 2018SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Monday, January 29, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 2, 2018APPLICATION FILING RECEIPT MAILED
Wednesday, March 14, 2018ASSIGNED TO EXAMINER
Monday, March 19, 2018NON-FINAL ACTION WRITTEN
Tuesday, March 20, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 26, 2018REFUSAL PROCESSED BY MPU
Monday, March 26, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, April 20, 2018REFUSAL PROCESSED BY IB
Saturday, May 19, 2018NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Friday, August 10, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, September 25, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 25, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 25, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 26, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 24, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 24, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 24, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, November 13, 2018PUBLISHED FOR OPPOSITION
Tuesday, November 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, November 23, 2018NOTIFICATION PROCESSED BY IB
Tuesday, January 29, 2019REGISTERED-PRINCIPAL REGISTER
Monday, April 29, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, May 20, 2019FINAL DISPOSITION PROCESSED
Monday, May 20, 2019FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 26, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, December 15, 2022CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, November 21, 2023NEW REPRESENTATIVE AT IB RECEIVED
Monday, January 29, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Wednesday, June 25, 2025TEAS SECTION 71 RECEIVED
Monday, July 14, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, July 15, 2025OFFICE ACTION ISSUED POU1
Wednesday, November 19, 2025NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, December 10, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 10, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 10, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, December 10, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 11, 2025TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Thursday, December 18, 2025PROOF OF USE INTERIM ACTION ISSUED